UroGen Pharma Ltd.

URGN Nasdaq SEC CIK 1668243
Follow UroGen Pharma Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $89M +223.9% vs same quarter last year
Net income −$1.5M +95.6% vs same quarter last year
EPS, diluted −$0.03 +95.7% vs same quarter last year
Operating cash flow −$15.2M +64% vs same quarter last year
Revenue by quarter
$24.6M
$20.3M
$24.2M
$27.5M
$37.8M
$51M
$72.5M
$89M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income12 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100M$200MFY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$109.8M−$153.5M
FY24$90.4M−$126.9M
FY23$82.7M−$102.2M
FY22$64.4M−$109.8M
FY21$48M−$110.8M
FY20$11.8M−$128.5M
FY19$18K−$105.1M
FY18$1.1M−$75.7M
FY17$8.2M−$20M
FY16$17.5M−$1.9M
FY15-−$12.7M
FY14--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−800000%−600000%−400000%−200000%0%200000%FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2588.7%−113.7%−139.8%
FY2490.2%−107.1%−140.4%
FY2388.7%−79.2%−123.6%
FY2288.1%−122.8%−170.6%
FY2189.3%−192.1%−230.7%
FY2091.4%−1074.2%−1088.9%
FY19100%−608211.1%−584144.4%
FY18−59.8%−6842.2%−6707.2%
FY1792.6%−244.5%−245.2%
FY1699.8%4.6%−11.1%
FY15---
FY14---
Free cash flowOperating cash flow minus capital expenditure
−$200M−$150M−$100M−$50M$0$50MFY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$162.7M
FY24−$97.1M
FY23−$76.6M
FY22−$87.8M
FY21−$85.6M
FY20−$107.1M
FY19−$71.3M
FY18−$37.9M
FY17−$9.8M
FY16$3.5M
FY15−$7.5M
FY14-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • UroGen Pharma Ltd.
  • Healthcare median
−600000%−400000%−200000%0%FY15FY17FY19FY21FY23FY25
Show the numbers
YearUroGen Pharma Ltd.Healthcare median
FY25−139.8%−30.6%
FY24−140.4%−47%
FY23−123.6%−58%
FY22−170.6%−80.4%
FY21−230.7%−71.8%
FY20−1088.9%−62.2%
FY19−584144.4%−46.2%
FY18−6707.2%−49.6%
FY17−245.2%−45.9%
FY16−11.1%−36%
FY15-−37.8%
FY14-−35.5%